Refining MDR-TB Treatment (T) Regimens (R) for Ultra(U) Short(S) Therapy(T)

Clinical trial NCT03867136 · COMPLETED

Trial details

NCT number: NCT03867136
Sponsor: Huashan Hospital
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Multidrug Resistant Tuberculosis

Start date: 2020-06-01
Primary completion: 2024-08-10
Enrollment: 354

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.